Treats Adults

Luis G Ortega Paz, MD

Cardiologist

Additional languages:: Spanish

(904) 383-1011

Request appointment online

Established patients New patients

Research at a glance

Research activity

67 publications

67 citations

Why is this important?

Active clinical trials

Switching from Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention: TAILOR-BLEED-2 study

Investigators: Dominick J Angiolillo, Luis G Ortega Paz
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

The Bridging Antiplatelet Therapy with Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens

Investigators: Dominick J Angiolillo, Luis G Ortega Paz
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

My publications

67 publications

2026

Trends in 90-Day Mortality, Recurrent Venous Thrombosis, and Bleeding in Patients With Pulmonary Embolism

JACC

Publisher's site

2026

Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y12 Inhibitor Therapy

JACC: Advances

Publisher's site

2026

Safety and Efficacy of Colchicine across the Spectrum of Coronary Artery Disease: A Systematic Review and Meta‐Analysis of 20 Randomized Trials

Clinical Pharmacology & Therapeutics

Publisher's site

2025

Association of body mass index on 10-year outcomes in patients treated with percutaneous coronary intervention and drug-eluting stents (the DECADE cooperation)

European Journal of Preventive Cardiology

Publisher's site

2025

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists

JACC

Publisher's site